Cargando…

Postpartum hepatitis and host immunity in pregnant women with chronic HBV infection

In order to develop immune tolerant to the fetal, maternal immune system will have some modification comparing to the time before pregnancy. Immune tolerance starts and develops at the maternal placental interface. In innate immunity, decidual natural killer (dNK) cells, macrophages and dendritic ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lu, Jiang, Tingting, Yang, Ying, Deng, Wen, Lu, Huihui, Wang, Shiyu, Liu, Ruyu, Chang, Min, Wu, Shuling, Gao, Yuanjiao, Hao, Hongxiao, Shen, Ge, Xu, Mengjiao, Chen, Xiaoxue, Hu, Leiping, Yang, Liu, Bi, Xiaoyue, Lin, Yanjie, Lu, Yao, Jiang, Yuyong, Li, Minghui, Xie, Yao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846060/ https://www.ncbi.nlm.nih.gov/pubmed/36685527 http://dx.doi.org/10.3389/fimmu.2022.1112234

Ejemplares similares

Study on liver histopathology of chronic HBV infected patients with different normal ALT values
por: Zeng, Zhan, et al.
Publicado: (2022)

Hepatitis B core-related antigen serum levels may be a predictor of acute flare of chronic hepatitis B among pregnant women in the immune-tolerant phase of chronic HBV infection after short-course antiviral therapy
por: Liu, Ruyu, et al.
Publicado: (2023)

Study on pathological and clinical characteristics of chronic HBV infected patients with HBsAg positive, HBV DNA negative, HBeAg negative
por: Zeng, Zhan, et al.
Publicado: (2023)

Functional molecular expression of nature killer cells correlated to HBsAg clearance in HBeAg-positive chronic hepatitis B patients during PEG-IFN α-2a therapy
por: Cao, Weihua, et al.
Publicado: (2022)

Dynamic changes of the proportion of HLA-DR and CD38 coexpression subsets on T lymphocytes during IFN-based chronic hepatitis B treatment
por: Lin, Yanjie, et al.
Publicado: (2023)

The relation of the frequency and functional molecules expression on plasmacytoid dendritic cells to postpartum hepatitis in women with HBeAg-positive chronic hepatitis B virus infection
por: Wang, Fuchuan, et al.
Publicado: (2022)

Cytokine profiles and CD8+ T cells in the occurrence of acute and chronic hepatitis B
por: Xie, Si, et al.
Publicado: (2022)

Changes of natural killer cells’ phenotype in patients with chronic hepatitis B in intermittent interferon therapy
por: Bi, Xiaoyue, et al.
Publicado: (2023)

Sustained viral response and relapse after discontinuation of oral antiviral drugs in HBeAg-positive patients with chronic hepatitis B infection
por: Sun, Fangfang, et al.
Publicado: (2022)

Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis B
por: Li, Minghui, et al.
Publicado: (2022)

A nomogram based on HBeAg, AST, and age to predict non-minimal liver inflammation in CHB patients with ALT <80 U/L
por: Zhang, Lu, et al.
Publicado: (2023)

Effects of hepatitis B virus infection and strategies for preventing mother-to-child transmission on maternal and fetal T-cell immunity
por: Lu, Huihui, et al.
Publicado: (2023)

Immune Mechanisms Underlying Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients With Viral Coinfection
por: Wu, Shuling, et al.
Publicado: (2022)

Effect of Antiviral Therapy During Pregnancy on Natural Killer Cells in Pregnant Women With Chronic HBV Infection
por: Wang, Fuchuan, et al.
Publicado: (2022)

The Characteristics of Natural Killer Cells in Chronic Hepatitis B Patients Who Received PEGylated-Interferon versus Entecavir Therapy
por: Cao, Weihua, et al.
Publicado: (2021)

Nomogram for evaluating obvious liver inflammation in treatment-naïve HBeAg positive chronic hepatitis B virus infection patients with normal ALT
por: Zhang, Lu, et al.
Publicado: (2023)

The reduction in CD8(+)PD-1(+) T cells in liver histological tissue is related to Pegylated IFN-α therapy outcomes in chronic hepatitis B patients
por: Liu, Ruyu, et al.
Publicado: (2020)

Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patients
por: Li, Minghui, et al.
Publicado: (2022)

Advances in Metagenomics and Its Application in Environmental Microorganisms
por: Zhang, Lu, et al.
Publicado: (2021)

Emerging nanobiotechnology for precise theranostics of hepatocellular carcinoma
por: Xu, Mengjiao, et al.
Publicado: (2022)

Expression of Functional Molecule on Plasmacytoid Dendritic Cells Is Associated With HBsAg Loss in HBeAg-Positive Patients During PEG-IFN α-2a Treatment
por: Cao, Weihua, et al.
Publicado: (2022)

Severe coagulopathy caused by cefminox sodium in a liver cirrhosis patient: a case report
por: Wu, Shuling, et al.
Publicado: (2022)

An optimized mode of interferon intermittent therapy help improve HBsAg disappearance in chronic hepatitis B patients
por: Li, Minghui, et al.
Publicado: (2022)

Clinical Features and T Cell Immune Characteristics of Postpartum Hepatitis Flare in Pregnant Women With HBeAg-Positive Chronic HBV Infection
por: Song, Aixin, et al.
Publicado: (2022)

Consolidation treatment needed for sustained HBsAg-negative response induced by interferon-alpha in HBeAg positive chronic hepatitis B patients
por: Li, Minghui, et al.
Publicado: (2022)

Association of neutrophil-lymphocyte ratio and T lymphocytes with the pathogenesis and progression of HBV-associated primary liver cancer
por: Liu, Xiaoli, et al.
Publicado: (2017)

Efficacy of Nucleot(s)ide Analogs Therapy in Patients with Unresectable HBV-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: He, Lingling, et al.
Publicado: (2017)

Impact of gender as a prognostic factor in HBV-related Hepatocellular Carcinoma: the survival strength of female patients in BCLC stage 0-B
por: Yu, Lihua, et al.
Publicado: (2019)

Editorial: Interferon and its antiviral effect in response to HBV infection
por: Song, Hongxiao, et al.
Publicado: (2023)

High Prevalence of Preexisting HBV Polymerase Mutations in Pregnant Women Does Not Limit the Antiviral Therapy Efficacy
por: Wang, Jing, et al.
Publicado: (2021)

Application of Lab-on-Chip for Detection of Microbial Nucleic Acid in Food and Environment
por: Yang, Liu, et al.
Publicado: (2021)

Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis
por: Xia, Xiaoxue, et al.
Publicado: (2018)

S gene mutations of HBV in children with HBV-associated glomerulonephritis
por: Lu, Hongzhu, et al.
Publicado: (2012)

The dose of HBV genome contained plasmid has a great impact on HBV persistence in hydrodynamic injection mouse model
por: Li, Lei, et al.
Publicado: (2017)

Chronic HBV infection among pregnant women and their infants in Shenyang, China
por: Ding, Yang, et al.
Publicado: (2013)

Oral Health Status and Literacy/Knowledge Amongst Pregnant Women in Shanghai
por: Hu, Wenqi, et al.
Publicado: (2022)

Dynamic changes of HBV markers and HBV DNA load in infants born to HBsAg(+) mothers: can positivity of HBsAg or HBV DNA at birth be an indicator for HBV infection of infants?
por: Chen, Tianyan, et al.
Publicado: (2013)

Postpartum pulmonary circulation in pregnant rats with monocrotaline-induced pulmonary arterial hypertension
por: Jing, He, et al.
Publicado: (2020)

Epidemiology of HBV in Pregnant Women, South West Nigeria
por: Atilola, Glory, et al.
Publicado: (2018)

An HBV-encoded miRNA activates innate immunity to restrict HBV replication
por: Zhao, Xiaoqing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vq54ahdguf31ju17fvctgsr5jq